title: Kinetic aspects of Ki-67 antigen expression in a normal cell line.
abstract: Using a normal cell line derived from a human fetus, the disappearance and reappearance of the Ki-67-reactive antigen following modification of the cell cycle was observed and estimated immunohistologically. It was found that G1/G0 arrest induced by serum deprivation resulted in loss of the antigen in 24 h in all but a few (usually less than 10%) of cells. Return to normal medium and resumption of growth was accompanied by reappearance in 30 h. When entry into S-phase was prevented by desferrioxamine, reappearance of the antigen still occurred but only lasted for about 24 h. Inhibition of protein synthesis with cycloheximide also caused fading and eventual loss of immunostaining. In view of the ease with which this antigen becomes undetectable with cessation of protein synthesis and interruption of the cell cycle, we agree with those who advise caution in the use of Ki-67 to measure growth fraction in changeable cell populations such as tumours.
authors.affiliation: Department of Morbid Anatomy, King's College School of Medicine and Dentistry, Denmark Hill, London, England.
authors.forename: R J
authors.initials: RJ
authors.lastname: Littleton
authors.forename: G M
authors.initials: GM
authors.lastname: Baker
authors.forename: I N
authors.initials: IN
authors.lastname: Soomro
authors.forename: R L
authors.initials: RL
authors.lastname: Adams
authors.forename: W F
authors.initials: WF
authors.lastname: Whimster
mesh_terms: D001769:Blood; D002453:Cell Cycle; D002455:Cell Division; D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004622:Embryo, Mammalian; D016193:G1 Phase; D006801:Humans; D019394:Ki-67 Antigen; D007700:Kinetics; D009369:Neoplasms / Q000473:pathology; D009687:Nuclear Proteins / Q000032:analysis / Q000378:metabolism*; D016192:Resting Phase, Cell Cycle; D016196:S Phase
chemical_list: D019394:Ki-67 Antigen; D009687:Nuclear Proteins; D003513:Cycloheximide; D003676:Deferoxamine